PAPA JOSEPH C — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

PAPA JOSEPH C has filed 4 SEC Form 4 filings across 3 companies in the last 90 days — buying. Lifetime open-market purchases: $350K.

Profile

PAPA JOSEPH C

Joseph C. Papa is a seasoned executive in the biopharmaceutical industry, currently serving as the President and CEO of Milestone Pharmaceuticals Inc. He has held various leadership roles across multiple companies, focusing on the development and commercialization of innovative therapies.

RoleInsider
Notability50/100
LinksWikipedia

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-05-01EBSEmergent BioSolutions Inc.A — Grant or award187.7K$0.00
2026-03-06EBSEmergent BioSolutions Inc.F — Tax withholding / forfeiture37.1K$8.44$313K
2025-07-11MISTMilestone Pharmaceuticals Inc.A — Grant or award100.0K
2025-06-25CADLCandel Therapeutics, Inc.A — Grant or award64.2K$4.67$300K
2025-05-13EBSEmergent BioSolutions Inc.P — Open-market purchase60.0K$5.83$350K

Companies — Last 90 Days

Frequently Asked Questions

Who is PAPA JOSEPH C?

Joseph C. Papa is a seasoned executive in the biopharmaceutical industry, currently serving as the President and CEO of Milestone Pharmaceuticals Inc. He has held various leadership roles across multiple companies, focusing on the development and commercialization of innovative therapies.…

How many SEC Form 4 filings has PAPA JOSEPH C submitted recently?

4 primary Form 4 filings in the last 90 days, covering 3 companies.

Has PAPA JOSEPH C been buying or selling stock?

Recorded transactions: 1 open-market purchases ($350K) and 0 open-market sales () across all tracked filings.

Where can I see all of PAPA JOSEPH C's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live PAPA JOSEPH C profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.